🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This phase II trial compares the effect of adding radiation therapy to the ...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-10-18
Trial ID
NCT06350162
Treatments Being Tested
The hypothesis of this study is that total knee alignment will be improved ...
Status
Completed
Location
Palo Alto VA HCS
Start Date
2010-11
Trial ID
NCT01242085
Treatments Being Tested
The combination of pEBV DNA (half-life) and PET-CT following 1 course of ch...
Status
Completed
Location
Department of Clinical Oncology, Prince of Wales Hospital
Start Date
2011-07
Trial ID
NCT01365208
Treatments Being Tested
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
The purpose of this study is to compare IV contrast only vs. IV and oral co...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00734825
Treatments Being Tested
The goal of this study is to use ultra-high-resolution (UHR) PET imaging to...
Status
Recruiting
Location
UZ Leuven
Start Date
2026-02-13
Trial ID
NCT07509125
The purpose of this study was to explore the potential application of spect...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-05-22
Trial ID
NCT06433817
Treatments Being Tested
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791